SCHEMBL15313242

SCHEMBL15313242

CC(=O)N(CCN(C(N)=O)c1ccccc1Br)c1cccc(C)c1.CCN(CCNC(=O)Nc1ccccc1Br)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.43
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 2/20 0.43
GAA P10253 1/20 0.43
GFER P55789 2/20 0.39
LMNA P02545 2/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
TSHR P16473 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15313243 0.91 MAPT (0.49) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL31679065 0.83 GFER (0.53) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL6732278 0.83 GFER (0.53) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL2727185 0.83 RAB9A (0.42) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL15310779 0.81 ALDH1A1 (0.45) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL2724077 0.81 MTNR1A (0.47) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL15253519 0.79 GFER (0.42) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL2723101 0.79 KMT2A (0.64) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL19205502 0.78 KMT2A (0.55) MAPTKMT2AMEN1SMN1; SMN2HTT
SCHEMBL2724952 0.77 GFER (0.44) MAPTKMT2AMEN1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240189303-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII 2024-06-13 US disclosed
US-20190192508-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2019-06-27 US disclosed
US-20150352105-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-12-10 US disclosed
US-9084786-B2 Methods and compositions for prevention and treatmentof cardiac hypertrophy UNIVERSITY OF HAWAII (US) 2015-07-21 US disclosed
US-20130274271-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENTOF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII (US) 2013-10-17 US disclosed